| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |